UK to donate 100 million vaccines to poorest countries

British Prime Minister Boris Johnson has announced that the UK will donate at least 100 million excess coronavirus vaccine doses over the next year, including 5.0 million from the coming weeks.

The donation complements the UK’s work to support Oxford-AstraZeneca’s contribution to the fight against COVID and UK financial support for COVAX, UNB reports.

The UK will donate 5.0 million doses by the end of September, starting in the coming weeks, mostly for use in the world’s poorest countries.

The Prime Minister also pledged to donate 95 million additional doses over the next year, including 25 million more by the end of 2021.

About 80 percent of the 100 million doses will go to COVAX and the rest will be shared bilaterally with countries in need.

By sharing 5.0 million doses in the coming weeks, the UK will meet an immediate demand for vaccines for countries worst affected by the coronavirus without delaying the completion of our initial national vaccination program.

Last week, the British Prime Minister asked his fellow G7 leaders to help immunize the whole world by the end of next year.

By vaccinating more people around the world, not only will we help end the global coronavirus pandemic, but we will reduce the risk to people in the UK.

This includes the significant reduction in the threat posed by vaccine-resistant variants emerging in areas with large-scale epidemics.

The UK helped establish COVAX last year and is its fourth donor, pledging £ 548million to the program.

COVAX has so far delivered 81 million doses to 129 of the world’s poorest countries. 96% of these were the Oxford-AstraZeneca vaccine, the development of which was funded by the UK.

With the support of the UK government, Oxford-AstraZeneca distributes its vaccines on a non-profit basis around the world.

Prime Minister Boris Johnson has said that since the start of this pandemic, the UK has led the way in efforts to protect humanity from this deadly disease.

Over a year ago, we funded the development of the Oxford-AstraZeneca vaccine on the basis that it would be distributed at cost to the world.

“This unprecedented model, which puts people above profit, means more than half a billion doses have been administered in 160 countries so far,” he said.

Thanks to the success of the UK vaccination program, we are now able to share some of our excess doses with those who need them. In doing so, we will take a giant step towards defeating this pandemic for good.

The doses the UK has announced it will give today will be taken from the expected oversupply in the UK.

The 100 million figure was calculated based on the total needed to vaccinate the UK population, taking into account the possibility of detection of future vaccine resistant strains and potential disruption to our supply.

Previous Adjusting to bench life a season-long learning experience for CU Buffs’ Nique Clifford – Greeley Tribune
Next Lack of engineering skills challenges UK electric vehicle market | Durability